IP Group
www.ipgroupplc.com
IP Group was founded in 2001 and is listed on the main market of the LSE. It invests in companies underpinned by IP and scientific innovation, across HealthTech, DeepTech, CleanTech. Investments are sourced via partnerships with universities (including Oxford, Cambridge, Imperial and UCL), research institutions and other networks. The on-balance-sheet portfolio value is>£0.9bn, with >£0.5bn managed for 3rd parties. The portfolio has produced 4 unicorns and realised >£1.1bn.
New venture growth mandate boosts fee prospects
IP Group has been appointed by Aberdeen Investments to manage a UK venture growth portfolio, via...
Read moreIP Group CEO & CFOO Interview: the model, exits and holdings to watch
To mark IP Group’s 25th anniversary, Equity Development analyst Paul Bryant spoke to CEO Greg Smith...
Read moreStrong H1, exits up sharply, solid portfolio FV rise
Strong H1 performance, NAV per share increased to 114p at H1 and c.117p by 11 September, driven by...
Read moreFocused venture investor with wave of exits ahead
IP Group (IPG) is a venture investor, holding c. £0.9bn of investments on-balance-sheet, with c....
Read morePositive phase 2 trial for new cystic fibrosis drug
IP Group portfolio company, Enterprise Therapeutics, has announced positive results from its Phase...
Read moreChair Designate is Michael Queen, ex CEO of 3i
Chair appointment: IP Group has appointed Michael Queen (ex‑CEO of 3i) as Chair Designate,...
Read more- Prev
- 1 of 1 pages
Register to be first
Get research on the companies that interest you straight to your inbox
